AUPH: Aurinia Pharmaceuticals Growth-Adjusted Market Cap to Net Income

Brandmark of Aurinia Pharmaceuticals (AUPH)

Aurinia Pharmaceuticals (AUPH) is scaling Lupkynis sales while optimizing costs for a potential acquisition deal. The growth stock undervaluation ratio confirms this potential, where 0.00 determines the current magnitude of the indicator. Development is based on the expansion of renal pathology therapies into new regions. The stable capacities of external partners fully cover the demand for immune drugs.

AUPH Aurinia Pharma: Price/Earnings to Growth Ratio in the range 07/04/2022 - 11/16/2026

Metric breakdowns and analytics for Aurinia Pharma (AUPH)

- share price and consensus valuation forecast:
General company analysis:AUPH - Aurinia Pharma
Signature product of Aurinia Pharmaceuticals Inc

This metric compares the current P/E multiple with the earnings growth rate, identifying undervalued assets when the value falls below one. For Aurinia Pharmaceuticals (AUPH), which is targeting expansion in lupus nephritis therapy, the P/E to EPS growth ratio serves as an indicator of drug commercialization efficiency, helping to distinguish a temporary price dip from fundamental business degradation.

Competing companies

ARGX (Argenx) - Growth-Adjusted Payback Ratio|PEG Multiple BNTX (biontech.de)|Growth-Adjusted Market Cap to Net Income Abivax S.A. (ABVX)|ADMA - Price/Earnings to Growth Ratio|Protagonist Therapeutics, Inc. (PTGX) - Price/Earnings to Growth Multiple|Immunovant Therapeutics (IMVT) - Price/Earnings to Growth Ratio|Price/Earnings to Growth Multiple Kiniksa Pharmaceuticals|Price/Earnings to Growth Multiple GRFS|PEG Multiple adaptivebiotech.com|Price/Earnings to Growth Ratio Celldex (CLDX)|BioCryst Pharmaceuticals - Growth-Adjusted P/E Ratio|PEG Multiple VERA (veratx.com)|Dianthus Pharma (DNTH) - Price to Earnings Adjusted for Growth Rate|PHVS - Price/Earnings to Growth Ratio|ABCL - PEG Multiple|Tourmaline (TRML) - Price/Earnings to Growth Ratio|Precigen - Growth-Adjusted Payback Ratio|PHAR (Pharming Group NV) - PEG Multiple|PEG Multiple Nektar Therapeutics|Price/Earnings to Growth Ratio Upstream Bio Inc (UPB)|PEG Multiple zenasbio.com (ZBIO)|Price/Earnings to Growth Ratio Immunome Corp IMNM|PEG Multiple Gossamer Bio Inc GOSS|KALV - Price/Earnings to Growth Ratio|Growth-Adjusted Payback Ratio SEPN (Septerna Pharma)|PVLA (Pieris Pharmaceuticals) - Price/Earnings to Growth Multiple|Savara Inc. - Growth-Adjusted Payback Ratio|RIGL (Rigel Pharmaceuticals, Inc.) - PEG Multiple|Price/Earnings to Growth Ratio ANAB|PEG Multiple ATXS|ENGN - Price to Earnings Adjusted for Growth Rate|PEG Multiple RAPT (rapt.com)|Company Value to Earnings Growth Ratio JBIO (Aerovate)|Aclaris Therapeutics, Inc - PEG Multiple|Price to Earnings Adjusted for Growth Rate Kyverna Therapeutics Inc.|TLSA: PEG Multiple|CABA - Growth-Adjusted Market Cap to Net Income|VTYX (ventyxbio.com) - PEG Multiple|Price to Earnings Adjusted for Growth Rate Theratechnologies Inc. THTX|Price/Earnings to Growth Multiple AVTX (avalotx.com)|Price/Earnings to Growth Multiple Eledon Pharmaceuticals, Inc. ELDN|Price/Earnings to Growth Ratio Agenus, Inc AGEN|Climb Bio Inc - Price/Earnings to Growth Ratio|Zura Bio Limited - PEG Multiple|Growth-Adjusted Market Cap to Net Income aTyr Pharma, Inc. ATYR|ADAG: PEG Multiple|Market Cap to Earnings and Growth Ratio IMA (ImageneBio)|Price/Earnings to Growth Multiple STTK|EQ: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Connect Pharma (CNTB)|PEG Multiple Immunic Therapeutics (IMUX)|PEG Multiple ATRA (Atara Biotherapeutics)|Growth-Adjusted Payback Ratio IFRX|XFOR (X4 Pharma) - Price to Earnings Adjusted for Growth Rate|Growth-Adjusted Payback Ratio ACET (adicetbio.com)|CELU: PEG Multiple|inmunebio.com (INMB) - PEG Multiple|BRNS (Barinthus Biotherapeutics PLC) - PEG Multiple|KZR: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio SAB Biotherapeutics, Inc. (SABS)|AKTX (Akari Therapeutics plc) - Growth-Adjusted Payback Ratio|Price/Earnings to Growth Ratio Enlivex Therapeutics Ltd ENLV|QTTB - Price/Earnings to Growth Multiple|geovax.com - PEG Multiple|Growth-Adjusted Payback Ratio EDSA (Edesa Biotech Inc)|IBIO: PEG Multiple|Carisma Tx (CARM) - PEG Multiple|XTLB (XTL Biopharmaceuticals) - PEG Multiple|BOLT: Growth-Adjusted Payback Ratio|Price/Earnings to Growth Multiple HCWB (HCW Biologics, Inc.)|PEG Multiple Aptevo (APVO)|PEG Multiple AIM (aimimmuno.com)|PEG Multiple Aditxt Corp ADTX|GRI: Price/Earnings to Growth Multiple|Growth-Adjusted Payback Ratio XRTX (xortx.com)|Vyome Holdings Inc. (HIND) - Price/Earnings to Growth Ratio|Revelation Bio (REVB) - PEG Multiple|INDP (Indaptus Corp) - PEG Multiple|SCNI: Growth-Adjusted Payback Ratio|PEG Multiple CALI|Price/Earnings to Growth Multiple Affimed N.V. AFMD|Price/Earnings to Growth Ratio Allakos ALLK|HOOK: Growth-Adjusted P/E Ratio|IGMS - Price/Earnings to Growth Ratio|Growth-Adjusted Market Cap to Net Income iTeos Therapeutics ITOS|Ocean Biomedical (OCEA) - Price/Earnings to Growth Ratio|tcbiopharm.com (TCBP) - PEG Multiple|THRD (Third Harmonic Bio Inc.) - PEG Multiple